To evaluate the efficacy and safety of KP-496NS for patients with perennial allergic rhinitis
Phase 2
- Conditions
- Perennial allergic rhinitis
- Registration Number
- JPRN-UMIN000001809
- Lead Sponsor
- KAKEN PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients having diseases that could interfere with assessment of treatment (2) Patients are/having recieved treatment for diseases that could interfere with assessment of treatment (3) Patients with bleeding tendency (4) Patients with problems in safety
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method